Cost-effectiveness and sustainability of breast cancer screening and new anti-cancer drugs

J Med Econ. 2017 Apr;20(4):405-408. doi: 10.1080/13696998.2017.1285306. Epub 2017 Feb 16.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Agents / economics*
  • Antineoplastic Agents / therapeutic use*
  • Breast Neoplasms / diagnosis*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Cost-Benefit Analysis
  • Early Detection of Cancer / economics*
  • Female
  • Humans
  • Survival Analysis

Substances

  • Antineoplastic Agents